|
SPC24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.20340000000641E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.577750E-04 |
| Normal-vs-Stage2 |
9.798200E-02 |
| Normal-vs-Stage3 |
1.200990E-04 |
| Normal-vs-Stage4 |
2.33549999999472E-05 |
| Stage1-vs-Stage2 |
7.011700E-02 |
| Stage1-vs-Stage3 |
3.799800E-01 |
| Stage1-vs-Stage4 |
4.560400E-02 |
| Stage2-vs-Stage3 |
1.917530E-02 |
| Stage2-vs-Stage4 |
2.378700E-03 |
| Stage3-vs-Stage4 |
2.247600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.89849999999914E-05 |
| Normal-vs-AfricanAmerican |
4.588400E-04 |
| Normal-vs-Asian |
1.661560E-02 |
| Caucasian-vs-AfricanAmerican |
4.832000E-01 |
| Caucasian-vs-Asian |
7.240200E-02 |
| AfricanAmerican-vs-Asian |
6.947700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.438000E-04 |
| Normal-vs-Female |
7.80160000000141E-05 |
| Male-vs-Female |
9.283800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.16119999999487E-05 |
| Normal-vs-Age(41-60Yrs) |
3.198500E-03 |
| Normal-vs-Age(61-80Yrs) |
5.52379999999575E-05 |
| Normal-vs-Age(81-100Yrs) |
6.469700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.501800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.825600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.425200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.144110E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.408030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.857800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.288800E-01 |
| Classical-VS-Follicular |
2.57780000012531E-07 |
| Classical-VS-Other |
4.970200E-01 |
| Classical-VS-Normal |
2.42250000004329E-06 |
| Tall-VS-Follicular |
1.604390E-04 |
| Tall-VS-Other |
2.774600E-01 |
| Tall-VS-Normal |
6.11589999999218E-05 |
| Follicular-VS-Other |
3.274200E-01 |
| Follicular-VS-Normal |
3.731600E-01 |
| Other-VS-Normal |
1.714640E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.316530E-03 |
| Normal-vs-N1 |
1.359320E-03 |
| N0-vs-N1 |
7.060200E-01 |
|
|
